Trials / Conditions / Critical Limb Ischemia (CLI)

Critical Limb Ischemia (CLI)

20 registered clinical trials studyying Critical Limb Ischemia (CLI) — 4 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Comprehensive Limb Evaluation and Arterial Revascularization With Toe Pressure Optimization Registry NCT07014072	University Hospital, Bordeaux	N/A
Enrolling By Invitation	Follow-up Study Using Gene Therapy for Critical Limb Ischemia (NL003-CLI-III-L) NCT07023965	Beijing Northland Biotech. Co., Ltd.	—
Recruiting	Initial Feasibility Study of the STENTiT Resorbable Fibrillated Scaffold (RFS). The RFS is Intended to Restore NCT07006467	Stentit	N/A
Recruiting	Pressure (Fractional Flow Reserve) and Flow (Vascular Flow Reserve) Measurements During Peripheral Arterial In NCT07052435	Dr. Konstantinos Katsanos	—
Completed	Ultrasound-Guided Sciatic Popliteal Nerve Block vs. Erector Spinae Plane Block in Endovascular Management of C NCT06913348	Minia University Hospital	—
Active Not Recruiting	LIFE-BTK PK Sub-study NCT05208905	Abbott Medical Devices	N/A
Unknown	IBS Titan vs. PTA in Patients With Infrapopliteal Arterial Stenosis or Occlusive Disease NCT04849325	Biotyx Medical (Shenzhen) Co., Ltd.	N/A
Completed	DCB Outcomes After Plain or Scoring Balloon for Vessel Preparation in Patients With Femoropopliteal Arterial D NCT07136883	Marc Sirvent	N/A
Active Not Recruiting	LIFE-BTK Randomized Controlled Trial NCT04227899	Abbott Medical Devices	N/A
Completed	Efficacy, Tolerability and Safety of Intramuscular Injections of PLX PAD for the Treatment of Subjects With Cr NCT03006770	Pluristem Ltd.	Phase 3
Terminated	The Efficacy and Safety of REX-001 to Treat Ischemic Ulcers in Subjects With CLI Rutherford Category 5 and DM NCT03174522	Ixaka Ltd	Phase 3
Terminated	The Efficacy and Safety of REX-001 to Treat Ischemic Rest Pain in Subjects With CLI Rutherford Category 4 and NCT03111238	Ixaka Ltd	Phase 3
Unknown	Critical Limb Ischemia Rapid Delivery by SurgWerks-CLI Kit and VXP System NCT02538978	Cesca Therapeutics, Inc.	Phase 3
Terminated	Clinical Trial I/II Opened, Randomized and Controlled for the Study of the Use of Stem Cells Therapy in Insuli NCT02287974	Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud	Phase 1 / Phase 2
Completed	Safety Study of Bone Marrow Cell Concentrate Prepared Using the Magellan System to Treat Critical Limb Ischemi NCT01386216	Arteriocyte, Inc.	Phase 1
Completed	Intra-arterial Infusion of Autologous Bone Marrow Mononuclear Cells in Non-diabetic Patients With Critical Lim NCT01408381	Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud	Phase 2
Completed	Human Adipose Derived Mesenchymal Stem Cells for Critical Limb Ischemia (CLI) in Diabetic Patients NCT01257776	Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud	Phase 1 / Phase 2
Completed	Intraarterial Infusion of Autologous Bone Marrow in Diabetic Patients With Chronic Ischemia of Lower Limbs (CL NCT00987363	Andalusian Initiative for Advanced Therapies - Fundación Pública Andaluza Progreso y Salud	Phase 1 / Phase 2
No Longer Available	Expanded Access Treatment of Subjects With Critical Limb Ischemia (CLI) With Minor Tissue Loss Who Are Unsuita NCT03886506	Pluristem Ltd.	—
Available	Expanded Access for Treatment Use of PLX-PAD in Critical Limb Ischemia (CLI) NCT03746899	WideTrial, Inc.	—